Correlation Between GlaxoSmithKline PLC and Goldman Sachs
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Goldman Sachs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Goldman Sachs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Goldman Sachs ETF, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Goldman Sachs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Goldman Sachs. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Goldman Sachs.
Diversification Opportunities for GlaxoSmithKline PLC and Goldman Sachs
0.22 | Correlation Coefficient |
Modest diversification
The 3 months correlation between GlaxoSmithKline and Goldman is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Goldman Sachs ETF in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Goldman Sachs ETF and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Goldman Sachs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Goldman Sachs ETF has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Goldman Sachs go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and Goldman Sachs
Considering the 90-day investment horizon GlaxoSmithKline PLC is expected to generate 2709.4 times less return on investment than Goldman Sachs. But when comparing it to its historical volatility, GlaxoSmithKline PLC ADR is 81.91 times less risky than Goldman Sachs. It trades about 0.0 of its potential returns per unit of risk. Goldman Sachs ETF is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 0.00 in Goldman Sachs ETF on August 26, 2024 and sell it today you would earn a total of 5,030 from holding Goldman Sachs ETF or generate 9.223372036854776E16% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 22.34% |
| Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. Goldman Sachs ETF
Performance |
| Timeline |
| GlaxoSmithKline PLC ADR |
| Goldman Sachs ETF |
GlaxoSmithKline PLC and Goldman Sachs Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GlaxoSmithKline PLC and Goldman Sachs
The main advantage of trading using opposite GlaxoSmithKline PLC and Goldman Sachs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Goldman Sachs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Goldman Sachs will offset losses from the drop in Goldman Sachs' long position.| GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
| Goldman Sachs vs. SSGA Active Trust | Goldman Sachs vs. SPDR Nuveen Municipal | Goldman Sachs vs. Xtrackers California Municipal | Goldman Sachs vs. iShares Short Maturity |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Complementary Tools
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| CEOs Directory Screen CEOs from public companies around the world |